These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 22653497)
1. Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts. Zhu C; Cheng KW; Ouyang N; Huang L; Sun Y; Constantinides P; Rigas B Stem Cells; 2012 Oct; 30(10):2065-75. PubMed ID: 22653497 [TBL] [Abstract][Full Text] [Related]
2. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway. Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways. Liao S; Gan L; Qin W; Liu C; Mei Z Oncol Rep; 2018 Oct; 40(4):2005-2013. PubMed ID: 30066938 [TBL] [Abstract][Full Text] [Related]
4. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition. Deng S; Wong CKC; Lai HC; Wong AST Oncotarget; 2017 Apr; 8(16):25897-25914. PubMed ID: 27825116 [TBL] [Abstract][Full Text] [Related]
5. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Li Y; Zhang T; Korkaya H; Liu S; Lee HF; Newman B; Yu Y; Clouthier SG; Schwartz SJ; Wicha MS; Sun D Clin Cancer Res; 2010 May; 16(9):2580-90. PubMed ID: 20388854 [TBL] [Abstract][Full Text] [Related]
6. B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells. Zhou H; Yu C; Kong L; Xu X; Yan J; Li Y; An T; Gong L; Gong Y; Zhu H; Zhang H; Yang X; Li Y Oncogene; 2019 May; 38(18):3371-3386. PubMed ID: 30635656 [TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway. Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904 [TBL] [Abstract][Full Text] [Related]
8. PGE Lin MC; Chen SY; He PL; Herschman H; Li HJ Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109 [TBL] [Abstract][Full Text] [Related]
9. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine. Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114 [TBL] [Abstract][Full Text] [Related]
10. Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells. Li X; Wang X; Xie C; Zhu J; Meng Y; Chen Y; Li Y; Jiang Y; Yang X; Wang S; Chen J; Zhang Q; Geng S; Wu J; Zhong C; Zhao Y Anticancer Drugs; 2018 Mar; 29(3):208-215. PubMed ID: 29356693 [TBL] [Abstract][Full Text] [Related]
11. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway. Xu W; Lin H; Zhang Y; Chen X; Hua B; Hou W; Qi X; Pei Y; Zhu X; Zhao Z; Yang L J Exp Clin Cancer Res; 2011 Oct; 30(1):103. PubMed ID: 22032476 [TBL] [Abstract][Full Text] [Related]
12. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment. Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248 [TBL] [Abstract][Full Text] [Related]
13. VEGF-A/Neuropilin 1 Pathway Confers Cancer Stemness via Activating Wnt/β-Catenin Axis in Breast Cancer Cells. Zhang L; Wang H; Li C; Zhao Y; Wu L; Du X; Han Z Cell Physiol Biochem; 2017; 44(3):1251-1262. PubMed ID: 29179185 [TBL] [Abstract][Full Text] [Related]
14. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft. Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913 [TBL] [Abstract][Full Text] [Related]
15. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling. Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949 [TBL] [Abstract][Full Text] [Related]
16. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling. Wang N; Wang Z; Peng C; You J; Shen J; Han S; Chen J Carcinogenesis; 2014 Nov; 35(11):2544-54. PubMed ID: 25194164 [TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Al-Dhfyan A; Alhoshani A; Korashy HM Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884 [TBL] [Abstract][Full Text] [Related]
18. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy. Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199 [TBL] [Abstract][Full Text] [Related]
19. Anthocyanin-containing purple-fleshed potatoes suppress colon tumorigenesis via elimination of colon cancer stem cells. Charepalli V; Reddivari L; Radhakrishnan S; Vadde R; Agarwal R; Vanamala JK J Nutr Biochem; 2015 Dec; 26(12):1641-9. PubMed ID: 26383537 [TBL] [Abstract][Full Text] [Related]
20. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma. Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]